Revenue and operating results improved year-over-year, driven by Animal Care sales and cost control. Ongoing regulatory progress in Human Care and a successful rights issue support future growth, though further financing is needed.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.